Bradner et al..
Chemical Phylogenetics of Histone Deacetylases, Nature Chemical Biology, 2010 Hutt et al..
Reduced Histone Deacetylase 7 Activity Restores Function to Misfolded CFTR in Cystic Fibrosis, Nature Chemical Biology, 2009 Chinmay A. Deshmane, Jacek B. Jasinski, Paul Ratnasamy and Moises A. Carreon.
Synthesis and catalytic properties of mesoporous, bifunctional, gallium–niobium mixed oxides, Chem. Commun., 2010, 46, 6347. Darren Griffith, Maria P. Morgan and Celine J. Marmion.
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity, Chem. Commun., 2009,
, 6735. Russell B. Williams, Jon C. Henrikson, Ashley R. Hoover, Andrlynn E. Lee and Robert H. CichewiczGraduate Program in Ecology and Evolutionary Biology..
Epigenetic remodeling of the fungal secondary metabolome, Org. Biomol. Chem., 2008, 6, 1895. Jon C. Henrikson, Ashley R. Hoover, P. Matthew Joyner and Robert H. Cichewicz.
A chemical epigenetics approach for engineering the in situbiosynthesis of a cryptic natural product from Aspergillus niger, Org. Biomol. Chem., 2009, 7, 435. Vaishnavi Srinivasaraghavan, Jeannine Strobl and Masoud Agah.
Bioimpedance rise in response to histone deacetylase inhibitor is a marker of mammary cancer cells within a mixed culture of normal breast cells, Lab Chip, 2012, 12, 5168. Li Youxuan, Woster Patrick M..
Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group, Med. Chem. Commun., 2015 Bürli Roland W., Luckhurst Christopher A., Aziz Omar, Matthews Kim L., Yates Dawn, Lyons Kathy. A., Beconi Maria, McAllister George, Breccia Perla, Stott Andrew J., Penrose Stephen D., Wall Michael, Lamers Marieke, Leonard Philip, Müller Ilka, Richardson Christine M., Jarvis Rebecca, Stones Liz, Hughes Samantha, Wishart Grant, Haughan Alan F., O’Connell Catherine, Mead Tania, McNeil Hannah, Vann Julie, Mangette John, Maillard Michel, Beaumont Vahri, Munoz-Sanjuan Ignacio, Dominguez Celia.
Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease, Journal of Medicinal Chemistry, 2013 Zhang Xin, Lv Peng-Cheng, Li Dong-Dong, Zhang Wei-Ming, Zhu Hai-Liang.
Navigating into the chemical space between MGCD0103 and SAHA: novel histone deacetylase inhibitors as a promising lead, Med. Chem. Commun., 2015